Dark

NBIX
Neurocrine Biosciences Inc
stock NASDAQ

Market Open

Oct 22, 2025 2:40:32 PM EDT

142.00USD-0.484%(-0.69)257,148

141.64Bid 142.05Ask 0.41Spread

Pre-market

0.00USD-100.000%(-141.33)0

After-hours

Oct 21, 2025 4:29:30 PM EDT

142.65USD-0.028%(-0.04)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

14.07B

CEO

Kevin Gorman

Headquarters

San Diego, California, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Oct 30, 2025 (8d)

RGEN ATHX LLY PFE PTN ABBV ANIP CASI PRTK XLV

NBIX Stats

Avg. Vol. 10 Day

638,277

Avg. Vol. 30 Day

809,715

Employees

470

Market Cap

14,073,856,269

Shares Out.

99,181,510

On/Off Exchange

66%/34%

6 Month Beta

0.62

1 Year Beta

0.84

2 Year Beta

0.74

3 Year Beta

0.62

52 Week Low

84.23

52 Week High

154.61

SMA50

139.06

SMA200

126.60

1 Week

+3.03%

1 Month

-3.22%

3 Month

+6.89%

6 Month

+39.47%

1 Year

+21.51%

2 Year

+31.50%

5 Year

+47.00%

Profile

neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders

NBIX Stock Summary

Neurocrine Biosciences Inc (NASDAQ:NBIX) stock price today is $142.00, and today's volume is 257,148. NBIX is down -0.484% today. The 30 day average volume is 809,715. NBIX market cap is 14.07B with 99,181,510 shares outstanding.